Skip to main content Skip to office menu Skip to footer
Minnesota Legislature

FOURTEENTH MEETING - Commerce

2019-2020 Regular Session

STATE OF MINNESOTA FOURTEENTH MEETING
HOUSE OF REPRESENTATIVES NINETY-FIRST SESSION

COMMERCE COMMITTEE

MINUTES

Representative Laurie Halverson, Chair of the Commerce Committee, called the meeting to order at 2:35PM on March 5th, 2019, in Room 120 of the State Capitol.

The Committee Legislative Assistant noted the roll.

Members present:

HALVERSON, Laurie, Chair
STEPHENSON, Zack, Vice Chair
O’DRISCOLL, Tim, GOP Lead
CARLSON, Andrew
DAVIDS, Gregory
DEHN, Raymond
ELKINS, Steve
GAROFALO, Pat
HOWARD, Michael
KOTYZA-WITTHUHN, Carlie
LESCH, John
LISLEGARD, Dave
MAHONEY, Tim
O’NEILL, Marion
RICHARDSON, Ruth
SWEDZINSKI, Chris
TABKE, Brad
THEIS, Tama

Members excused:

HALEY, Barb
KRESHA, Ron

A quorum was present.

Representative Stephenson moved to approve the minutes of March 1st, 2019. THE MOTION PREVAILED.


HF284 (Halverson)
Insulin products sold in Minnesota cost review authorized by commissioner of health, excessive cost determined, maximum level of reimbursement established for insulin products if necessary, and money appropriated.

Representative Halverson moved HF284 to be re-referred to the Health and Human Services Policy Division, and moved the HF0284A1 (Halverson) amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.

Testifiers in support of HF284:
Quinn Nystrom, Diabetes Advocate

Testifiers in opposition of HF284:
Kristina Moorhead, Senior Director of State Advocacy, PhRMA

Representative Halverson renewed the motion for HF284 to be re-referred, as amended, to the Health and Human Services Policy Division. THE MOTION PREVAILED.

HF485 (Howard)
Insulin assistance program established, insulin assistance account established in the special revenue fund, drug manufacturers required to pay an insulin product fee, emergency refills provided, and money appropriated.

Representative Howard moved HF485 to be re-referred to Health and Human Services Policy Division, and moved the HF0485DE1-1 (Howard) amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.

Testifiers in support of HF485:
Erin Murphy, former State Representative
Nicole Smith-Holt and James Holt, Parents of Alec Smith, and Insulin for All advocates
Shari Wiltrout, Parents of diabetic children

Testifiers in opposition of HF485:
Kristina Moorhead, Senior Director of State Advocacy, PhRMA

Representative Howard renewed the motion to move HF485, as amended, to be re-referred to Health and Human Services Policy Division. THE MOTION PREVAILED.

HF289 (Mann)
Diabetes prescription drugs cost reporting required.

Representative Halverson moved HF289 to be re-referred to Health and Human Services Policy Division, and moved the HF0289A2 (Mann) amendment.



Testifiers in support of HF289:
Dr. Stephen Schondelmeyer
Christine Fallabel, American Diabetes Association

Testifiers in opposition of HF289:
Kristina Moorhead, Senior Director of State Advocacy, PhRMA

Representative Halverson renewed the motion to move HF289 to be re-referred to Health and Human Services Policy Division. THE MOTION PREVAILED.

HF288 (Masin)
Health plan companies prohibited from removing coverage of insulin or equipment and supplies during an enrollee’s contract year.

Representative Halverson moved HF288 to be re-referred Health and Human Services Policy Division, and moved the HF0288A19-0085 (Masin) amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.

Testifiers in support of HF288:
Christine Fallabel, American Diabetes Association
Taylor Metzer
John Williams
Deb Salter

Representative Halverson renewed the motion to move HF289 to be re-referred to Health and Human Services Policy Division. THE MOTION PREVAILED.

HF359 (Becker-Finn)
Flame-retardant chemical use in certain products prohibited.

Representative Halverson moved HF359 to be re-referred to Health and Human Services Policy Division.

Testifiers in support of HF359:
Jenna Grove, Legislative Program Coordinator, Clean Water Action
Chris Parsons, President, Minnesota Professional Fire Fighters

Testifiers in opposition of HF359:
Bruce Nustad, President, Minnesota Retailers Association
Lloyd Grooms, American Chemistry Council

Representative Halverson renewed the motion for HF359 to be re-referred to Health and Human Services Policy Division. THE MOTION PREVAILED.

Chair Halverson recessed the committee at 4:43PM.

Chair Halverson reconvened the committee at 5:32PM.

HF963 (Halverson)

Representative Halverson moved HF963 to be re-referred to Health and Human Services Policy Division.

Testifiers in support of HF963:
Laura Hermer
Dr. Erin Stevens, Minnesota Chapter, American College of Obstetricians and Gynecologists (ACOG)
Hannah Maycock
Anita Smithson, Read Testimony by Representative Carlson

Representative Halverson renewed the motion HF963 to be re-referred to Health and Human Services Policy Division.

The meeting was adjourned at 5:55PM.






Representative Laurie Halverson, Chair




Aimee Vue,
Committee Legislative Assistant

``









More Info On This Meeting..
Agenda:

Bills may be taken in any order. HF 485 (Howard) Insulin assistance program established, insulin assistance account established in the special revenue fund, drug manufacturers required to pay an insulin product fee, emergency refills provided, and money appropriated. HF 289 (Mann) Diabetes prescription drugs cost reporting required. HF 288 (Masin) Health plan companies prohibited from removing coverage of insulin or equipment and supplies during an enrollee's contract year. HF 284 (Halverson) Insulin products sold in Minnesota cost review authorized by commissioner of health, excessive cost determined, maximum level of reimbursement established for insulin products if necessary, and money appropriated. HF 963 (Halverson) Prescription contraceptives supply requirements established; health plans required to cover contraceptive methods, sterilization, patient education, counseling, and related medical services; and eligible organization accommodations established. ***BILL ADDED*** HF 359 (Becker-Finn) Flame-retardant chemical use in certain products prohibited. If you would like to testify, please email the committee administrator: Laura.Taken-Holtze@house.mn Please note that public testimony will be limited to no more than THREE MINUTES per testifier. If you have any handouts, please provide 100 copies to the Committee Legislative Assistant Aimee Vue (503 State Office Building) by 10:00 a.m. on Tuesday, 3/5/19.

Bills Added:
  • HF485 (Howard) - Pharmaceutical assistance program established, insulin assistance account in the special revenue fund established, fees and penalties established, and money appropriated.
  • HF284 (Halverson) - Insulin products sold in Minnesota cost review authorized by commissioner of health, excessive cost determined, maximum level of reimbursement established for insulin products if necessary, and money appropriated.
  • HF288 (Masin) - Health plan companies prohibited from removing coverage of insulin or equipment and supplies during an enrollee's contract year.
  • HF289 (Mann) - Diabetes prescription drugs cost reporting required.
  • HF963 (Halverson) - Prescription contraceptives supply requirements established; health plans required to cover contraceptive methods, sterilization, patient education, counseling, and related medical services; and eligible organization accommodations established.
  • HF359 (Becker-Finn) - Flame-retardant chemical use in certain products prohibited, and exemptions allowed.
Hearing Documents:
Audio Available:
Listen Now